Ketorolac Tromethamine Injection

Pfizer Inc

Revision date : 2012-07-13

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

200-578-6/64-17-5

Name of the chemical

Ethanol

Concentration

10

EC/CAS

215-185-5/1310-73-2

Name of the chemical

sodium hydroxide

Concentration

N/A

EC/CAS

231-595-7/7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

N/A

EC/CAS

231-791-2/7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

80-85

General Information

Version

2.0

Revision date

2012-07-13

Product name

Ketorolac Tromethamine Injection

Product name

Ketorolac Tromethamine Injection

Identification on the label/Trade name

Not applicable

Chemical name

Mixture

1.2.1 Relevant identified uses

Pharmaceutical product used as non-steroidal, anti-inflammatory drug (nsaid)

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

M004 M009 M010 M017 GHS08

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

DANGER

Hazard Codes

Hazard statements (CLP)

H360D

Hazard statements

Code

Statements

H360D

May damage the unborn child

Section 2

SECTION 2: Hazards identification

Appearance Clear to light yellow solution

Signal word

DANGER

Hazard statements

May damage the unborn child. May cause damage to gastrointestinal system through prolonged or repeated exposure.

Additional information

Short Term Accidental ingestion may cause effects similar to those seen in clinical use. Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Known Clinical Effects Other nonsteroidal anti-inflammatory drugs (NSAIDs) are known to impact delivery, late fetal development, and lactation. Ingestion of this material may cause effects similar to those seen in clinical use including serious gastrointestinal toxicity such as bleeding, ulceration, and perforation and kidney toxicity. Clinical use of this drug has caused headache, dizziness, blurred vision, ringing of the ears, skin rash, itching, swelling, liver effects. EU Indication of danger Toxic to reproduction: Category 1 Harmful EU Hazard Symbols EU Risk Phrases R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. R61 - May cause harm to the unborn child. Australian Hazard Classification (NOHSC)

Hazardous Ingredients

Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Hazardous Substance. Dangerous Goods. (NOHSC)

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.